COVID-19 with acute cholecystitis: a case report
Abstract Background The 2019 novel coronavirus (COVID-19) presents a major threat to public health and has rapidly spread worldwide since the outbreak in Wuhan, Hubei Province, China in 2019. To date, there have been few reports of the varying degrees of illness caused by the COVID-19. Case presentation A case of 68-year-old female with COVID-19 pneumonia who had constant pain in the right upper quadrant of her abdomen during her hospitalization that was finally diagnosed as acute cholecystitis. Ultrasound-guided percutaneous transhepatic gallbladder drainage (PTGD) was performed, and the real-time fluorescence polymerase chain reaction (RT-PCR) COVID-19 nucleic acid assay of the bile was found to be negative. PTGD, antibacterial and anti-virus combined with interferon inhalation treatment were successful. Conclusion The time course of chest CT findings is typical for COVID-19 pneumonia. PTGD is useful for acute cholecystitis in COVID-19 patients. Acute cholecystitis is likely to be caused by COVID-19 ..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
BMC Infectious Diseases - 20(2020), 1, Seite 4 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mingliang Ying [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
2019-nCoV |
|---|
| doi: |
10.1186/s12879-020-05164-7 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ045986185 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ045986185 | ||
| 003 | DE-627 | ||
| 005 | 20230308101529.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12879-020-05164-7 |2 doi | |
| 035 | |a (DE-627)DOAJ045986185 | ||
| 035 | |a (DE-599)DOAJ51d830893ff24485b97280376a2a581e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC109-216 | |
| 100 | 0 | |a Mingliang Ying |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COVID-19 with acute cholecystitis: a case report |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Background The 2019 novel coronavirus (COVID-19) presents a major threat to public health and has rapidly spread worldwide since the outbreak in Wuhan, Hubei Province, China in 2019. To date, there have been few reports of the varying degrees of illness caused by the COVID-19. Case presentation A case of 68-year-old female with COVID-19 pneumonia who had constant pain in the right upper quadrant of her abdomen during her hospitalization that was finally diagnosed as acute cholecystitis. Ultrasound-guided percutaneous transhepatic gallbladder drainage (PTGD) was performed, and the real-time fluorescence polymerase chain reaction (RT-PCR) COVID-19 nucleic acid assay of the bile was found to be negative. PTGD, antibacterial and anti-virus combined with interferon inhalation treatment were successful. Conclusion The time course of chest CT findings is typical for COVID-19 pneumonia. PTGD is useful for acute cholecystitis in COVID-19 patients. Acute cholecystitis is likely to be caused by COVID-19 . | ||
| 650 | 4 | |a 2019-nCoV | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Pneumonia | |
| 650 | 4 | |a Computed tomography | |
| 650 | 4 | |a Acute cholecystitis | |
| 653 | 0 | |a Infectious and parasitic diseases | |
| 700 | 0 | |a Bin Lu |e verfasserin |4 aut | |
| 700 | 0 | |a Jiangfeng Pan |e verfasserin |4 aut | |
| 700 | 0 | |a Guanghong Lu |e verfasserin |4 aut | |
| 700 | 0 | |a Shaobin Zhou |e verfasserin |4 aut | |
| 700 | 0 | |a Dingjun Wang |e verfasserin |4 aut | |
| 700 | 0 | |a Lu Li |e verfasserin |4 aut | |
| 700 | 0 | |a Junkang Shen |e verfasserin |4 aut | |
| 700 | 0 | |a Jiner Shu |e verfasserin |4 aut | |
| 700 | 0 | |a From the COVID-19 Investigating and Research Team |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t BMC Infectious Diseases |d BMC, 2003 |g 20(2020), 1, Seite 4 |w (DE-627)DOAJ000056693 |x 14712334 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2020 |g number:1 |g pages:4 |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s12879-020-05164-7 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/51d830893ff24485b97280376a2a581e |z kostenfrei |
| 856 | 4 | 0 | |u http://link.springer.com/article/10.1186/s12879-020-05164-7 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1471-2334 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2020 |e 1 |h 4 | ||